Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CBLL
CBLL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CBLL News
CeriBell, Inc. Reports Strong Q4 2025 Earnings and Market Expansion
Feb 25 2026
seekingalpha
CeriBell Reports 2025 Financials and 2026 Outlook
Feb 25 2026
NASDAQ.COM
CeriBell Q4 Earnings Exceed Expectations
Feb 24 2026
seekingalpha
VentriPoint Diagnostics Secures $1 Million Funding to Propel AI Medical Imaging Growth
Jan 16 2026
Globenewswire
CeriBell (CBLL) Receives FDA Breakthrough Device Designation for Stroke Detection Monitor
Jan 05 2026
NASDAQ.COM
CeriBell CEO Jane Chao to Present at 2026 J.P. Morgan Healthcare Conference
Dec 30 2025
Globenewswire
Ventripoint Partners with Nisg̱a'a to Advance Cardiac Imaging in Remote Communities
Dec 12 2025
PRnewswire
Ventripoint Partners with Nisg̱a'a for Advanced Cardiac Imaging
Dec 12 2025
Newsfilter
CeriBell Stock Jumps 5.4% Following FDA Approval of Innovative Delirium EEG Device
Dec 09 2025
NASDAQ.COM
Major Stocks Including Academy Sports and Outdoors, Tronox, and STAAR Surgical See Gains on Tuesday
Dec 09 2025
Benzinga
Aleen Inc. Launches Personal Account System, Seeks $20M-$30M Investment
Dec 09 2025
Newsfilter
CeriBell Receives FDA Clearance for First Continuous Delirium Monitoring Device
Dec 09 2025
Newsfilter
CeriBell Receives FDA Clearance for Next-Gen Neonatal Seizure Detection Technology
Nov 24 2025
Newsfilter
CeriBell (CBLL) Third Quarter 2025 Earnings Call Summary
Nov 09 2025
NASDAQ.COM
JP Morgan Keeps Overweight Rating on CeriBell, Adjusts Price Target to $17
Nov 05 2025
Benzinga
TD Cowen Keeps Buy Rating on CeriBell, Reduces Price Target to $20
Nov 05 2025
Benzinga
Show More News
